368
Views
27
CrossRef citations to date
0
Altmetric
Reviews

The role of Toll-like receptors in chronic B cell malignancies

, , , &
Pages 1573-1580 | Received 22 Apr 2009, Accepted 13 Jun 2009, Published online: 08 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Bingqiao Huang, Aili He, Pengyu Zhang, Xiaorong Ma, Yun Yang, Jianli Wang, Jin Wang & Wanggang Zhang. (2020) Targeted silencing of genes related to acute monocytic leukaemia by CpG(B)-MLAA-34 siRNA conjugates. Journal of Drug Targeting 28:5, pages 516-524.
Read now
Maria Giovanna Vilia, Eleonora Fonte, Tania Veliz Rodriguez, Marta Tocchetti, Pamela Ranghetti, Lydia Scarfò, Nikos Papakonstantinou, Stavroula Ntoufa, Kostas Stamatopoulos, Paolo Ghia & Marta Muzio. (2017) The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia. Leukemia & Lymphoma 58:10, pages 2419-2425.
Read now
Maria Batool, Muhammad Ayaz Anwar & Sangdun Choi. (2016) Toll-like receptors targeting technology for the treatment of lymphoma. Expert Opinion on Drug Discovery 11:11, pages 1047-1059.
Read now
Martina Seiffert, Sascha Dietrich, Alexander Jethwa, Hanno Glimm, Peter Lichter & Thorsten Zenz. (2012) Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia. Leukemia & Lymphoma 53:6, pages 1023-1031.
Read now

Articles from other publishers (23)

Sylwia Sulimiera Michalak, Anna Olewicz-Gawlik, Joanna Rupa-Matysek, Edyta Wolny-Rokicka, Elżbieta Nowakowska & Lidia Gil. (2020) Autoimmune hemolytic anemia: current knowledge and perspectives. Immunity & Ageing 17:1.
Crossref
Bruno Fattizzo & Wilma Barcellini. (2020) Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects. Frontiers in Oncology 9.
Crossref
Srinivas Ramishetti & Dan Peer. (2019) Engineering lymphocytes with RNAi. Advanced Drug Delivery Reviews 141, pages 55-66.
Crossref
Agata Szymańska, Agnieszka Bojarska-Junak, Arkadiusz Drobiecki, Waldemar Tomczak, Jacek Roliński, Marek Hus & Iwona Hus. (2018) TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia. Archivum Immunologiae et Therapiae Experimentalis 67:1, pages 55-65.
Crossref
Eman L. Dadashian, Erin M. McAuley, Delong Liu, Arthur L. ShafferIIIIII, Ryan M. Young, Jessica R. Iyer, Michael J. Kruhlak, Louis M. Staudt, Adrian Wiestner & Sarah E. M. Herman. (2019) TLR Signaling Is Activated in Lymph Node–Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib. Cancer Research 79:2, pages 360-371.
Crossref
Xingli Zhao, Zhuoran Zhang, Dayson Moreira, Yu-Lin Su, Haejung Won, Tomasz Adamus, Zhenyuan Dong, Yong Liang, Hongwei H. Yin, Piotr Swiderski, Raju K. Pillai, Larry Kwak, Stephen Forman & Marcin Kortylewski. (2018) B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors. Molecular Therapy 26:3, pages 695-707.
Crossref
Martina Molgora, Domenico Supino, Alberto Mantovani & Cecilia Garlanda. (2018) Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8. Immunological Reviews 281:1, pages 233-247.
Crossref
Martina Molgora, Domenico Supino & Cecilia Garlanda. 2018. Immunopharmacology and Inflammation. Immunopharmacology and Inflammation 225 246 .
Jordina Rovira, Kennosuke Karube, Alexandra Valera, Dolors Colomer, Anna Enjuanes, Lluís Colomo, Alejandra Martínez-Trillos, Eva Giné, Ivan Dlouhy, Laura Magnano, Julio Delgado, Antonio Martínez, Neus Villamor, Elías Campo & Armando López-Guillermo. (2016) MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome . Clinical Cancer Research 22:11, pages 2755-2764.
Crossref
Martina Molgora, Isabella Barajon, Alberto Mantovani & Cecilia Garlanda. (2016) Regulatory Role of IL-1R8 in Immunity and Disease. Frontiers in Immunology 7.
Crossref
Basile Siewe, Joey T. Pham, Mardge Cohen, Nancy A. Hessol, Alexandra Levine, Otoniel Martinez-Maza & Alan Landay. (2015) Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma. AIDS 29:13, pages 1659-1664.
Crossref
Carlo Visco, Wilma Barcellini, Francesco Maura, Antonino Neri, Agostino Cortelezzi & Francesco Rodeghiero. (2014) Autoimmune cytopenias in chronic lymphocytic leukemia. American Journal of Hematology 89:11, pages 1055-1062.
Crossref
Sarah E. M. Herman, Rashida Z. Mustafa, Jennifer A. Gyamfi, Stefania Pittaluga, Stella Chang, Betty Chang, Mohammed Farooqui & Adrian Wiestner. (2014) Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL. Blood 123:21, pages 3286-3295.
Crossref
Federico Caligaris-Cappio, Maria T.S. Bertilaccio & Cristina Scielzo. (2014) How the microenvironment wires the natural history of chronic lymphocytic leukemia. Seminars in Cancer Biology 24, pages 43-48.
Crossref
Yu Guo, Basile Siewe, Marta Epeldegui, Roger Detels, Alan L. Landay & Otoniel Martínez-Maza. (2013) TLR2-Activated B Cells are Phenotypically Similar to the Abnormal Circulating B Cells Seen Preceding the Diagnosis of AIDS-Related NHL Diagnosis. JAIDS Journal of Acquired Immune Deficiency Syndromes 64:2, pages 204-210.
Crossref
Qifang Zhang, Dewan Md Sakib Hossain, Sergey NechaevAnna Kozlowska, Wang Zhang, Yong Liu, Claudia M. KowolikPiotr SwiderskiJohn J. RossiStephen Forman, Sumanta Pal, Ravi Bhatia, Andrew Raubitschek, Hua Yu & Marcin Kortylewski. (2013) TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo. Blood 121:8, pages 1304-1315.
Crossref
Reem Karmali, Laura A Paganessi, Robin R Frank, Sucheta Jagan, Melissa L Larson, Parameswaran Venugopal, Stephanie A Gregory & Kent W Christopherson. (2013) Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients. Journal of Leukocyte Biology 93:1, pages 161-170.
Crossref
Crystina L. KrissJavier A. Pinilla-IbarzAdam W. MaillouxJohn J. PowersChih-Hang Anthony TangChang Won Kang, Nicola Zanesi, Pearlie K. Epling-BurnetteEduardo M. SotomayorCarlo M. Croce, Juan R. Del Valle & Chih-Chi Andrew Hu. (2012) Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. Blood 120:5, pages 1027-1038.
Crossref
Jooeun Bae, Yu‐Tzu Tai, Kenneth C. Anderson & Nikhil C. Munshi. (2011) Novel epitope evoking CD138 antigen‐specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders. British Journal of Haematology 155:3, pages 349-361.
Crossref
Maria Teresa Sabrina BertilaccioGiorgia SimonettiAntonis DagklisMartina RocchiTania Veliz RodriguezBenedetta ApollonioAlberto MantovaniMaurilio Ponzoni, Paolo Ghia, Cecilia GarlandaFederico Caligaris-Cappio & Marta Muzio. (2011) Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood 118:3, pages 660-669.
Crossref
Emilie Domange Jordö, Fredrik Wermeling, Yunying Chen & Mikael C.I. Karlsson. (2011) Scavenger receptors as regulators of natural antibody responses and B cell activation in autoimmunity. Molecular Immunology 48:11, pages 1307-1318.
Crossref
Maurilio Ponzoni, Claudio Doglioni & Federico Caligaris-Cappio. (2011) Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment. Seminars in Diagnostic Pathology 28:2, pages 161-166.
Crossref
Yair HerishanuPatricia Pérez-GalánDelong LiuAngélique BiancottoStefania PittalugaBerengere VireFederica GibelliniNdegwa NjugunaElinor LeeLawrence StennettNalini RaghavachariPoching LiuJ. Philip McCoyMark RaffeldMaryalice Stetler-StevensonConstance YuanRichard SherryDiane C. ArthurIrina MaricTherese White, Gerald E. Marti, Peter MunsonWyndham H. Wilson & Adrian Wiestner. (2011) The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117:2, pages 563-574.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.